CURETIS

curetis-logo

Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

CURETIS

Social Links:

Industry:
Biotechnology Genetics Health Diagnostics Medical

Founded:
2007-01-01

Address:
Holzgerlingen, Baden-Wurttemberg, Germany

Country:
Germany

Website Url:
http://www.curetis.com

Total Employee:
11+

Status:
Active

Email Addresses:
contact@curetis.com

Total Funding:
75.1 M EUR

Technology used in webpage:
Euro Ninja Forms 3 To 9 CcTLD Redirects


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.


Current Advisors List

holger-reithinger_image

Holger Reithinger Board of Directors @ Curetis
Board_member

Current Employees Featured

johannes-bacher_image

Johannes Bacher
Johannes Bacher Co-Founder and COO @ Curetis
Co-Founder and COO

andreas-boos_image

Andreas Boos
Andreas Boos Co-Founder and CTO @ Curetis
Co-Founder and CTO
2008-01-01

achim-plum_image

Achim Plum
Achim Plum CBO @ Curetis
CBO
2017-12-01

oliver-schacht_image

Oliver Schacht
Oliver Schacht Managing Director @ Curetis
Managing Director
2011-04-01

Founder


andreas-boos_image

Andreas Boos

johannes-bacher_image

Johannes Bacher

Stock Details


Company's stock symbol is AMS:CURE

Investors List

european-investment-bank_image

European Investment Bank

European Investment Bank investment in Post-IPO Debt - Curetis

yorkville-advisors_image

Yorkville Advisors

Yorkville Advisors investment in Post-IPO Debt - Curetis

aeris-capital_image

Aeris Capital

Aeris Capital investment in Series B - Curetis

biomedpartners_image

BioMedPartners

BioMedPartners investment in Series B - Curetis

cd-venture_image

CD-Venture

CD-Venture investment in Series B - Curetis

hbm-partners_image

HBM Partners

HBM Partners investment in Series B - Curetis

forbion-capital-partners_image

Forbion Capital Partners

Forbion Capital Partners investment in Series B - Curetis

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series B - Curetis

life-sciences-partners_image

Life Sciences Partners

Life Sciences Partners investment in Series B - Curetis

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series A - Curetis

Newest Events participated

investor-talks-meet-young-german-high-growth-companies_event_image Participated in Investor Talks: Meet Young German High-Growth Companies on 2015-09-17 as exhibitor

investor-talks-meet-young-german-high-growth-companies_event_image Participated in Investor Talks: Meet Young German High-Growth Companies on 2015-09-14 as exhibitor

Official Site Inspections

http://www.curetis.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Curetis"

Curetis - Crunchbase Company Profile & Funding

Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases. …See details»

Curetis 2025 Company Profile: Valuation, Funding

Curetis General Information Description. Manufacturer of molecular diagnostic products intended to improve patient outcomes. The company offers a rapid …See details»

Curetis GmbH Information - RocketReach

Curetis has entered into several international distribution agreements covering many countries across Europe, the Middle East and Asia. In 2017, Curetis established Ares Genetics GmbH, a …See details»

Curetis Company Profile - Office Locations, Competitors ... - Craft

May 4, 2020 Curetis has 2 employees at their 1 location and €1.42 m in annual revenue in FY 2018. See insights on Curetis including office locations, competitors, revenue, financials, …See details»

Curetis CEO and Key Executive Team | Craft.co

Curetis's key executives include Oliver Schacht and 11 others. Oliver Schacht. CEO. Johannes Bacher. COO. Andreas Boos. CTO. Chris Emery. President & CEO, Curetis USA. Faranak …See details»

Curetis AG - Holzgerlingen, Germany

Aug 18, 2017 Curetis has entered into several international distribution agreements covering many countries across Europe, the Middle East and Asia. In 2017, Curetis established Ares …See details»

Curetis GmbH Overview | SignalHire Company Profile

Curetis GmbH is a private company that has been in the industry for 16 years. The company currently specializes in the Medical Devices, Biotechnology areas. ... Organization Website: …See details»

Curetis - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»

curetis (Curetis GmbH) - Startbase

Die neusten Erwähnungen von curetis in Podcasts & Videos: Offene Jobs bei curetis: Weitere Startups in der Nähe von curetis. NEWDRIVE Analytics. Startup 2022 Holzgerlingen. …See details»

Curetis - Contacts, Employees, Board Members, Advisors & Alumni

Curetis is a molecular diagnostic firm focused on the development and commercialization of tools for diagnosing severe infectious diseases. New. Resources. ... Log In. Experience the new …See details»

Curetis - Overview, News & Similar companies | ZoomInfo.com

Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 30, 2020, …See details»

Curetis - F6S

Similar companies GeneSys Bio s.r.l. Saving Lives by making infection detection faster and more accessible. Clemedi Clemedi: Give the right antibiotics! Hyris Biotech company active in the …See details»

Curetis - EQT Group

Curetis. Dental care with ambition. Curaeos is a fast-growing platform of dental clinics, with activities in the Netherlands, Belgium, Denmark, Germany and Italy. Key Facts. Sector. Life …See details»

Curetis - Raised $127M Funding from 13 investors - Tracxn

Feb 27, 2025 List of Curetis's institutional investors. BMBF, located in Berlin (Germany), made their first investment in Curetis on Sep 30, 2020 in its Grant (prize money) round.; European …See details»

Curetis | Science Company | Labroots

Oct 29, 2024 Curetis offers a rapid molecular diagnostic solution with broad coverage of pathogens and resistance markers.See details»

This Diagnostic Tool beats the Standard for Respiratory Infection …

Oct 25, 2016 Curetis is a German biotech that commercializes diagnostic technologies for infectious diseases. ... The World Health Organization (WHO) expects infectious diseases to …See details»

OpGen, Curetis to Merge, Creating $24M MDx Developer Focused …

Sep 6, 2019 “We are convinced that the combination of OpGen and Curetis will help maximize value for our stockholders and will result in an organization with a robust pipeline of molecular …See details»

Curetis Spins Out Antibiotic Resistance Test Company Ares Genetics

Apr 6, 2017 Molecular diagnostics firm Curetis was founded in 2007 to develop rapid diagnostics for severe infectious diseases. The Germany-based company’s flagship Unyvero platform and …See details»

OpGen Subsidiaries Curetis, Ares Genetics File for Bankruptcy

Nov 7, 2023 Curetis filed a petition for bankruptcy protection with the district court of Stuttgart, Germany, while Ares Genetics filed with the commercial court in Vienna. The insolvency …See details»

Otis CEO Judy Marks Inside the Strategy Room | McKinsey

Mar 11, 2025 Otis has been shaping urban mobility for over 170 years. CEO and Chair Judy Marks discusses how she steers the company through geopolitical shifts, technological …See details»

linkstock.net © 2022. All rights reserved